Real-time in-vivo measurement of myoglobin oxygen saturation

• US 5,931,779 A
• Filed: 06/06/1997
• Issued: 08/03/1999
• Est. Priority Date: 06/06/1996
• Status: Expired due to Term

• Current Assignee: University of Washington
• Original Assignee: Wisconsin Alumni Research Foundation (University of Wisconsin System)
• Inventors: Kushmerick, Martin J., Marble, David, Schenkman, Kenneth H., Feigl, Eric, Arakaki, Lorilee S., Burns, David H.
• Primary Examiner(s): O'Connor, Cary E.
• Assistant Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US08/870,483
• Time in Patent Office: 788 Days
• Field of Search: 600/310, 600/311, 600/323, 600/328, 600/340, 600/342, 600/473, 600/476
• US Class Current: 600/310
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence

Abstract

A method for determining myoglobin oxygen fractional saturation in vivo in muscle tissue and intracellular oxygen tension (pO₂), typically in the presence of hemoglobin, is provided. The method comprises measuring the absorption spectrum of the tissue using spectrographic equipment known to the art, including equipment for non-invasively taking spectroscopic measurements of tissue, or adaptations of such equipment to provide the preferred measurements described herein, or using spectrographic equipment specifically designed as described herein for use in non-invasive measurements of reflectance spectra. The measured spectrum is corrected for light scattering effects, such as by taking the second derivative of the data, or by using other means which are known to the art. Myoglobin fractional oxygen saturation is calculated from the measured spectrum employing calibration coefficients that are themselves calculated from application of multivariate analysis to a calibration set created from the second derivatives of absorption spectra. The calibration set spectra preferably representing absorbances of (1) a range of concentrations of hemoglobin (wherein a range of concentrations of oxyhemoglobin and deoxyhemoglobin are present), (2) one concentration of myoglobin (preferably selected to match the concentration of myoglobin in the target muscle tissue) with varying relative amounts of oxy- and deoxymyoglobin and (3) a range of concentrations of scattering agents to mimic scattering encountered in target tissue. The range of concentrations of oxy- and deoxyhemoglobin and the relative amounts of oxy- and deoxymyoglobin represented in calibration set spectra span the range of concentrations of these species encountered in the target tissue. Sample tissue spectra are preferably measured in the visible, the near-infrared or both wavelength ranges. Diffuse reflectance spectroscopy is the preferred method for obtaining spectral data. A partial least squares (PLS) method is preferably used to calculate calibration coefficients from the calibration set which in turn are used to calculate myoglobin oxygen saturation from the measured data. Other means known to the art may also be used. Measured myoglobin oxygen saturation determinations can be used to calculate intracellular oxygen tension, if accurate p50 values at appropriate physiologic pH and temperature for myoglobin-oxygen dissociation are available. An improved method of accurate determination of myoglobin-oxygen dissociation curves under physiologically relevant conditions is also provided.

Claims

1. A method for determining myoglobin fractional oxygen saturation in vivo in muscle tissue which comprises the steps of:

(a) measuring an absorption spectrum of a muscle tissue in vivo,

(b) calculating the myoglobin fractional oxygen saturation of said tissue from said measured absorption spectrum using calibration coefficients determined from multivariate analysis employing a calibration set comprising in vitro absorbance spectra wherein in the spectra of said calibration set myoglobin and hemoglobin saturation are varied independently of one another.

2. The method of claim 1 wherein in step (a) a derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises derivatives of said in vitro absorbance spectra.

3. The method of claim 1 wherein in step (a) second-derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises second-derivatives of said in vitro absorbance spectra.

4. The method of claim 1 wherein said muscle tissue is blood-perfused muscle tissue.

5. The method of claim 1 wherein said absorption spectrum is measured in the visible or near-infrared wavelength region.

6. The method of claim 1 wherein said absorption spectrum is measured using diffuse reflectance spectroscopy.

7. The method of claim 6 wherein said absorption spectrum is measured in the near-infrared wavelength region.

8. The method of claim 6 wherein said absorption spectrum is measured in the visible wavelength region.

9. The method of claim 6 wherein a reflectance spectrum is obtained employing a fiber optic contact probe comprising spatially separated illuminating and detection fibers.

10. The method of claim 9 wherein the minimal spacing between the illuminating and detection fibers in said fiber optic probe is between about 1 mm to about 3 mm.

11. The method of claim 1 wherein said multivariate analysis is a partial least squares analysis.

12. The method of claim 1 wherein a scattering agent is represented in spectra of said calibration set.

13. A method for determining intracellular oxygen tension in vivo in muscle tissue which comprises the steps of:

(a) determining the myoglobin fractional oxygen saturation of said muscle tissue in vivo by;

(i) measuring an absorption spectrum of a muscle tissue in vivo, and taking a derivative of said spectrum;

(ii) calculating the myoglobin fractional oxygen saturation of said tissue from said measured absorption spectrum using calibration coefficients determined from multivariate analysis employing a calibration set comprising derivatives in vitro absorbance spectra wherein in the spectra of said calibration set myoglobin and hemoglobin saturation are varied independently of one another; and

(b) calculating the intracellular oxygen tension of said muscle tissue from the oxygen saturation data of step(a) employing a p50 value obtained from an optical spectroscopic determination of myoglobin-oxygen dissociation curves.

14. The method of claim 13 wherein in step (a) a derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises derivatives of said in vitro absorbance spectra.

15. The method of claim 13 wherein in step (a) second-derivative of said spectrum is taken prior to step (b) and wherein in step (b) said calibration set comprises second-derivatives of said in vitro absorbance spectra.

16. The method of claim 13 wherein said myoglobin-oxygen dissociation curves are determined using multiwavelength spectroscopic analysis.

17. The method of claim 16 wherein said myoglobin-oxygen dissociation curves are determined by a method which compensates for the presence of metmyoglobin.

18. The method of claim 13, wherein said muscle tissue is blood-perfused muscle tissue.

19. The method of claim 13 wherein said absorption spectrum is measured in the visible or near-infrared wavelength region.

20. The method of claim 13 wherein said absorption spectrum is measured using diffuse reflectance spectroscopy.

21. The method of claim 20 wherein said absorption spectrum is measured in the near-infrared wavelength region.

22. The method of claim 20 wherein said absorption spectrum is measured in the visible wavelength region.

23. The method of claim 13 wherein said multivariate analysis is a partial least squares analysis.

24. The method of claim 13 wherein a scattering agent is represented in spectra of said calibration set.